Effects of immunosuppression on the efficacy of vaccination against Mycoplasma gallisepticum infection in chickens.

Vet Microbiol

Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia.

Published: September 2021

Immunosuppression can increase the susceptibility of chickens to other disease-causing pathogens and interfere with the efficacy of vaccination against those pathogens. Chicken anaemia virus (CAV) and infectious bursal disease virus (IBDV) are common causes of immunosuppression in chickens. Immunosuppression was induced by experimental infection with either CAV or IBDV to assess the effect of immunosuppression on the efficacy of vaccination with Mycoplasma gallisepticum strain ts-304 against infection with virulent M. gallisepticum, a common bacterial pathogen of chickens worldwide. Birds were experimentally infected with either CAV or IBDV at 1 week of age, before vaccination and challenge with M. gallisepticum to examine the effect of immunosuppression at the time of vaccination, or at 6 weeks of age, after vaccination against M. gallisepticum but before challenge with virulent M. gallisepticum, to investigate the effect of immunosuppression at the time of challenge. All birds were vaccinated with a single dose of the ts-304 vaccine at 3 weeks of age and experimentally challenged with the virulent M. gallisepticum strain Ap3AS at 8 weeks of age. In immunosuppressed chickens there was a reduction in protection offered by the ts-304 vaccine at two weeks after challenge, as measured by tracheal mucosal thicknesses, serum antibody levels against M. gallisepticum, air sac lesion scores and virulent M. gallisepticum load in the trachea. Immunosuppressed birds with detectable serum antibodies against M. gallisepticum were less likely to have tracheal lesions. This study has shown that immunosuppression caused by infection with CAV or IBDV can interfere with vaccination against mycoplasmosis in chickens.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetmic.2021.109182DOI Listing

Publication Analysis

Top Keywords

virulent gallisepticum
16
efficacy vaccination
12
cav ibdv
12
weeks age
12
gallisepticum
10
immunosuppression efficacy
8
vaccination mycoplasma
8
mycoplasma gallisepticum
8
chickens immunosuppression
8
infection cav
8

Similar Publications

Comparison of the Efficacy of Vaccine Programs in Chickens.

Avian Pathol

December 2024

Poultry Diagnostic and Research Center, Department of Population Health, University of Georgia, Athens, GA 30602-4875.

The efficacy of two commercially available vaccines administered singly or in combination was evaluated in two trials; in both trials, specific-pathogen-free (SPF) chickens were vaccinated with the live attenuated F-strain vaccine at 5 weeks of age (WOA), an inactivated bacterin at 9 and 13 WOA, or both vaccines. In the first trial, groups of vaccinated birds, along with controls, were challenged via aerosol with virulent R-strain at 22 and 41 weeks of age. All of the vaccine programs evaluated showed a statistically significant reduction in colonization with the challenge strain following challenge at either timepoint.

View Article and Find Full Text PDF
Article Synopsis
  • CRISPR-Cas systems are bacterial defenses that help combat viruses and genetic elements, but little is known about their evolution in new environments.* -
  • In a study of a poultry pathogen that shifted to a passerine host 30 years ago, researchers observed changes in CRISPR-Cas components, showing adaptations to new viral pressures.* -
  • Over time, isolates exhibited a rise in non-functional CRISPR-Cas systems, coinciding with the passerine host's resistance evolution, indicating that this inactivation may have been crucial for bacterial adaptation and increased virulence.*
View Article and Find Full Text PDF

Pathogen reinfections occur widely, but the extent to which reinfected hosts contribute to ongoing transmission is often unknown despite its implications for host-pathogen dynamics. House finches () acquire partial protection from initial exposure to the bacterial pathogen (MG), with hosts readily reinfected with homologous or heterologous strains on short timescales. However, the extent to which reinfected hosts contribute to MG transmission has not been tested.

View Article and Find Full Text PDF
Article Synopsis
  • * Current vaccines help a bit but aren't very effective or safe, so scientists created a new type of vaccine using special parts of the germ.
  • * The new vaccine showed good results in chickens, especially when combined with a specific ingredient that helped reduce illness and damage in their throats.
View Article and Find Full Text PDF

Variability of pMGA/vlhA sequences among Mycoplasma gallisepticum field strains isolated from laying hens and their deformed eggs.

Access Microbiol

June 2024

Departamento de Microbiología e Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Ciudad Universitaria, Universidad Nacional Autónoma de México, CDMX, 04510, México.

Mycoplasmosis, attributed to , poses a significant challenge to poultry farming, leading to substantial economic losses and persistent infections within flocks. This bacterium harbours various surface proteins that are crucial for adhesion, transporter activity and evasion of the host immune response, facilitating its pathogenicity. One such key surface lipoprotein, referred to as pMGA or vlhA haemagglutinin, plays a pivotal role in adhesion processes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!